Britain’s Medicines Regulatory Authority said on Thursday it has approved an antibody-based treatment for Covid-19 by AstraZeneca for patients with weak immune responses, a major step in the fight against the coronavirus pandemic.
The Medicines and Healthcare products Regulatory Agency said the decision to grant approval for the treatment was adopted by the government’s independent scientific advisory panel after reviewing the evidence.
The antibody mixture, called Evoshield, has already received regulatory approval in the United States for use in preventing COVID-19 infection in individuals with weakened immune systems or a history of serious side effects from coronavirus vaccines.
#Britain #approves #treatment #Corona #AstraZeneca